MALE BREAST CANCER: A RETROSPECTIVE ANALYSIS OF SINGLE CENTER RESULTS

Hakan BAYSAL, Ayşegül ERGÜN, Begümhan BAYSAL, Zeynep Çağla TARCAN, Mehmet Sait ÖZSOY, Fatih BÜYÜKER, Orhan ALİMOĞLU
{"title":"MALE BREAST CANCER: A RETROSPECTIVE ANALYSIS OF SINGLE CENTER RESULTS","authors":"Hakan BAYSAL, Ayşegül ERGÜN, Begümhan BAYSAL, Zeynep Çağla TARCAN, Mehmet Sait ÖZSOY, Fatih BÜYÜKER, Orhan ALİMOĞLU","doi":"10.20492/aeahtd.1335516","DOIUrl":null,"url":null,"abstract":"AIM
 Male breast cancers (MBC), constituting less than 1% of all breast carcinomas, are relatively rare. The average age of diagnosis is between 60-70 years and can affect males of all ages. In this study our aim was to present the clinicopathological characteristics, treatment, and survival outcomes of patients who were treated and followed up for ten years in out clinic, in accordance with literature. 
 MATERIAL AND METHOD
 Records of MBC patients who were followed and treated at our clinic between January 2014 and January 2023 were examined retrospectively using the hospital database. Clinicopathological characteristics, treatments performed, overall and disease-free survival rates were analyzed.
 RESULTS
 A total of 19 patients were included in the study (mean age: 75.9±11.5, range: 57-96). Four patients with distant metastasis and other system malignancies at the time of diagnosis were excluded. The mean follow-up period was 43.8 months. The most common location of the tumor was to be the retroareolar region (63.2%). BRCA2 gene mutation analysis was positive in three patients. Eleven patients (57.9%) were at Stage 3. Eleven patients had invasive ductal carcinoma. Twelve patients belong to the luminal B subtype. Among the 13 patients who underwent axillary dissection 9 (69.2%) had lymph node involvement. Patients who developed distant metastasis had higher overall mortality and cancer-specific mortality. The body mass index (BMI) of deceased patients was lower than that of surviving patients during the follow-up period. Age group above 75 years had lower overall survival (log-rank p=0.0064) and cancer-specific survival (log-rank p=0.011).
 CONCLUSION
 In our study, we found that distant metastasis significantly affected the survival. Although male breast cancers are rare, early diagnosis, as in women, positively influences overall and disease-free survival.","PeriodicalId":498730,"journal":{"name":"S.b. Ankara eğitim ve araştırma hastahanesi tıp dergisi","volume":"52 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"S.b. Ankara eğitim ve araştırma hastahanesi tıp dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20492/aeahtd.1335516","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

AIM Male breast cancers (MBC), constituting less than 1% of all breast carcinomas, are relatively rare. The average age of diagnosis is between 60-70 years and can affect males of all ages. In this study our aim was to present the clinicopathological characteristics, treatment, and survival outcomes of patients who were treated and followed up for ten years in out clinic, in accordance with literature. MATERIAL AND METHOD Records of MBC patients who were followed and treated at our clinic between January 2014 and January 2023 were examined retrospectively using the hospital database. Clinicopathological characteristics, treatments performed, overall and disease-free survival rates were analyzed. RESULTS A total of 19 patients were included in the study (mean age: 75.9±11.5, range: 57-96). Four patients with distant metastasis and other system malignancies at the time of diagnosis were excluded. The mean follow-up period was 43.8 months. The most common location of the tumor was to be the retroareolar region (63.2%). BRCA2 gene mutation analysis was positive in three patients. Eleven patients (57.9%) were at Stage 3. Eleven patients had invasive ductal carcinoma. Twelve patients belong to the luminal B subtype. Among the 13 patients who underwent axillary dissection 9 (69.2%) had lymph node involvement. Patients who developed distant metastasis had higher overall mortality and cancer-specific mortality. The body mass index (BMI) of deceased patients was lower than that of surviving patients during the follow-up period. Age group above 75 years had lower overall survival (log-rank p=0.0064) and cancer-specific survival (log-rank p=0.011). CONCLUSION In our study, we found that distant metastasis significantly affected the survival. Although male breast cancers are rare, early diagnosis, as in women, positively influences overall and disease-free survival.
男性乳腺癌:单中心结果的回顾性分析
目标# x0D;男性乳腺癌(MBC)占所有乳腺癌的比例不到1%,相对罕见。平均诊断年龄在60-70岁之间,可影响所有年龄段的男性。在这项研究中,我们的目的是根据文献,介绍在我们诊所接受治疗和随访10年的患者的临床病理特征、治疗和生存结果。& # x0D;材料与方法 2014年1月至2023年1月期间在我诊所随访和治疗的MBC患者的记录使用医院数据库进行回顾性检查。分析两组患者的临床病理特征、治疗情况、总生存率和无病生存率。 结果# x0D;共纳入19例患者,平均年龄75.9±11.5岁,范围57 ~ 96岁。排除4例诊断时有远处转移和其他系统恶性肿瘤的患者。平均随访时间为43.8个月。最常见的肿瘤部位为乳晕后区(63.2%)。3例患者BRCA2基因突变分析呈阳性。11例患者(57.9%)处于3期。11例为浸润性导管癌。12例患者属于腔内B亚型。13例腋清扫患者中有9例(69.2%)淋巴结受累。发生远处转移的患者总体死亡率和癌症特异性死亡率更高。在随访期间,死亡患者的体重指数(BMI)低于存活患者。75岁以上年龄组总生存率(log-rank p=0.0064)和癌症特异性生存率(log-rank p=0.011)较低。 结论# x0D;在我们的研究中,我们发现远处转移对生存率有显著影响。虽然男性乳腺癌很少见,但早期诊断(如女性)对总体生存率和无病生存率有积极影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书